Costa Rica vs Serbia: Treatment success rate for patients treated for MDR-TB
Costa Rica
100.0%
in 2019
Serbia
100.0%
in 2022
Costa Rica rank
1st
Serbia rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Costa Rica
- Serbia
How they compare
Costa Rica currently reports 100.0% against 100.0% in Serbia, a difference of 0.0%.
The two have swapped places 2 times across 5 shared years of data; in 2009 it was Costa Rica ahead.
Costa Rica ranks 1st and Serbia ranks 1st of 163 countries.
Costa Rica has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Costa Rica | Serbia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 60.0% | 40.0% | Costa Rica |
| 2010s | 77.0% | 70.2% | 6.8% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Costa Rica or Serbia?
- Costa Rica, at 100.0% against 100.0% in Serbia as of 2019.
- What is the difference in treatment success rate for patients treated for mdr-tb between Costa Rica and Serbia?
- 0.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Serbia?
- 5 years are reported by both, from 2009 to 2017.
- How do Costa Rica and Serbia rank globally for treatment success rate for patients treated for mdr-tb?
- Costa Rica ranks 1st and Serbia ranks 1st of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.